(Q34038749)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10996624%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

review article

1 reference

title

Antitumor vaccination using peptide based vaccines (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10996624%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10996624%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

author name string

E Bar-Haim

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10996624%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

K El-Shami

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10996624%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

publication date

1 September 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10996624%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10996624%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

volume

74

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10996624%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10996624%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

page(s)

27-34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10996624%20AND%20SRC:MED&resulttype=core&format=json

The biology of cancer metastasis and implications for therapy

10 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900245-5

7 January 2021

AN EXPERIMENTAL COMPARISON OF TRANSPLANTED TUMOR AND A TRANSPLANTED NORMAL TISSUE CAPABLE OF GROWTH

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900245-5

7 January 2021

Antigenicity of murine skin tumors induced by ultraviolet light

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900245-5

7 January 2021

Protection against a nonimmunogenic mouse leukemia by an immunogenic variant obtained by mutagenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900245-5

7 January 2021

MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900245-5

7 January 2021

Peptides naturally presented by MHC class I molecules

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900245-5

7 January 2021

Interactions between immunogenic peptides and MHC proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900245-5

7 January 2021

Immunity to oncogenic proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900245-5

7 January 2021

CTL induction by a tumour-associated antigen octapeptide derived from a murine lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900245-5

7 January 2021

Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900245-5

7 January 2021

Use of combinatorial peptide libraries to construct functional mimics of tumor epitopes recognized by MHC class I-restricted cytolytic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900245-5

7 January 2021

Tumor antigens recognized by T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900245-5

7 January 2021

Identification of Her-2/Neu CTL epitopes using double transgenic mice expressing HLA-A2.1 and human CD.8.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900245-5

7 January 2021

The makings of a tumor rejection antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900245-5

7 January 2021

A new era for cancer immunotherapy based on the genes that encode cancer antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900245-5

7 January 2021

Generation of human cytotoxic T cells specific for human carcinoembryonic antigen epitopes from patients immunized with recombinant vaccinia-CEA vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900245-5

7 January 2021

A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900245-5

7 January 2021

BAGE: a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900245-5

7 January 2021

A new gene coding for an antigen recognized by autologous cytolytic T lymphocytes on a human renal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900245-5

7 January 2021

Therapy of murine tumors with p53 wild-type and mutant sequence peptide-based vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900245-5

7 January 2021

Eradication of adenovirus E1-induced tumors by E1A-specific cytotoxic T lymphocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900245-5

7 January 2021

An intracisternal A-particle sequence codes for an antigen recognized by syngeneic cytolytic T lymphocytes on a mouse spontaneous leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900245-5

7 January 2021

A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900245-5

7 January 2021

A mutated beta-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900245-5

7 January 2021

A CASP-8 mutation recognized by cytolytic T lymphocytes on a human head and neck carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900245-5

7 January 2021

Self-tolerance to the murine homologue of a tyrosinase-derived melanoma antigen: implications for tumor immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900245-5

7 January 2021

Immunoselection in vivo: independent loss of MHC class I and melanocyte differentiation antigen expression in metastatic melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900245-5

7 January 2021

Identification of tyrosinase-related protein 2 as a tumor rejection antigen for the B16 melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900245-5

7 January 2021

Regression of established murine carcinoma metastases following vaccination with tumour-associated antigen peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900245-5

7 January 2021

Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900245-5

7 January 2021

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900245-5

7 January 2021

Novel methods to monitor antigen-specific cytotoxic T-cell responses in cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900245-5

7 January 2021

Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900245-5

7 January 2021

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900245-5

7 January 2021

Gene vaccination: plasmid DNA is more than just a blueprint

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900245-5

7 January 2021

Ox40-ligand has a critical costimulatory role in dendritic cell:T cell interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900245-5

7 January 2021

Processing of some antigens by the standard proteasome but not by the immunoproteasome results in poor presentation by dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900245-5

7 January 2021

Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900245-5

7 January 2021

Tumor eradication by wild-type p53-specific cytotoxic T lymphocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900245-5

7 January 2021

10.1016/S0165-2478(00)00245-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10996624%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference